- Home
- DSS vs EVOK Comparison
DSS vs EVOK Comparison
Compare DSS & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSS
- EVOK
- Stock Information
- Founded
- DSS 1984
- EVOK 2007
- Country
- DSS United States
- EVOK United States
- Employees
- DSS N/A
- EVOK N/A
- Industry
- DSS Containers/Packaging
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- DSS Consumer Discretionary
- EVOK Health Care
- Exchange
- DSS Nasdaq
- EVOK Nasdaq
- Market Cap
- DSS 7.3M
- EVOK 6.5M
- IPO Year
- DSS N/A
- EVOK 2013
- Fundamental
- Price
- DSS $0.85
- EVOK $4.30
- Analyst Decision
- DSS
- EVOK
- Analyst Count
- DSS 0
- EVOK 0
- Target Price
- DSS N/A
- EVOK N/A
- AVG Volume (30 Days)
- DSS 31.9K
- EVOK 29.5K
- Earning Date
- DSS 11-13-2024
- EVOK 03-13-2025
- Dividend Yield
- DSS N/A
- EVOK N/A
- EPS Growth
- DSS N/A
- EVOK N/A
- EPS
- DSS N/A
- EVOK N/A
- Revenue
- DSS $25,019,000.00
- EVOK $8,617,036.00
- Revenue This Year
- DSS N/A
- EVOK $97.35
- Revenue Next Year
- DSS N/A
- EVOK $99.52
- P/E Ratio
- DSS N/A
- EVOK N/A
- Revenue Growth
- DSS N/A
- EVOK 100.35
- 52 Week Low
- DSS $0.81
- EVOK $3.54
- 52 Week High
- DSS $2.30
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- DSS 41.29
- EVOK 43.99
- Support Level
- DSS $0.89
- EVOK $4.07
- Resistance Level
- DSS $0.99
- EVOK $4.59
- Average True Range (ATR)
- DSS 0.08
- EVOK 0.29
- MACD
- DSS -0.00
- EVOK -0.01
- Stochastic Oscillator
- DSS 0.00
- EVOK 29.49
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.